“Emerging Therapies Act of 2017” Signed into Arkansas Law
Posted on April 10th, 2017
Big announcement. We’re pleased to be the first to announce that “The Emerging Therapies Act of 2017” has been signed into law.
We are eager to work with other states to pass laws allowing state reimbursement of regenerative therapies. Allowing the body to heal itself is much more affordable than surgery, at a huge savings to the state – potentially saving Arkansas state medical system over $100 million. (1)
Dr David Harshfield, MD, a leading stem cell doctor and clinical researcher with The Soldara Institute pioneered this bill with several visionary legislators to make Arkansas the first state to reimburse stem cell therapies for state employees and educators.
Arkansas Governor Signs “Emerging Therapies Act of 2017”– Pilot Study will allow Regenerative Injection Therapies (RIT) to be covered on State Employee and Teacher health plans
Little Rock, ARK, April 10, 2017: The Emerging Therapies Act of 2017 was signed into law by Governor Asa Hutchinson today, granting pilot access to State Employees and Teachers to Regenerative Injection Therapies as a treatment of orthopedic conditions on their health care plans. Arkansas now leads the country as the first state to adopt a policy to include these emerging therapies in state employee health insurance.
“This could potentially save the state $100 Million using regenerative medicine as an alternative to surgery or pharmaceuticals for orthopedic conditions.” states Morgan Pile, Executive Vice President of Regenerative Medicine Solutions, who worked with HB2014 sponsors Senator David Sanders, Rep Joe Farrer and Rep Scott Baltz to bring the opportunity to the state. “Regenerative Injection Therapies like Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC) and Amniotic tissue have been shown to be effective treatments with up to an 80% savings of surgical costs with virtually absent complications.”
Dr. David L. Harshfield, Jr. – a clinical research doctor in ongoing studies with The Soldara Institute – is a pioneer in regenerative cellular therapy. He championed the bill with state legislatures and believes that Regenerative Medicine allows us to move away from the existing Allopathic medicine (M.D.) model, where a physician must match a diagnosis to only a binary, pharmaceutical or surgical solution.
Representative Scott Baltz has personal experience with these therapies, as his wife was advised that a surgical intervention might not provide more than 2 years’ relief of her symptoms, and could ultimately leave her with worse symptoms than she was experiencing. They elected to use Regenerative Injection Therapy (RIT) instead of a surgical procedure, and 4 years later she is still experiencing relief that allows her to raise her grandchildren and live a normal life. Representative Baltz realized that RIT was “something that could help other Arkansans if insurance would cover it.” His wife testified to the Employee Benefits Division (EBD) about the merits of this emerging therapy in 2014.
Morgan Pile, Strong Side Solutions
- Uth, Kristin, and Dimitar Trifonov. “Stem cell application for osteoarthritis in the knee joint: a minireview.” World J Stem Cells 6.5 (2014): 629-636. [full text]
- Arkansas House Bill 2014. [full text]